Evidence map›Paper›PMID 37294892›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2023

mTORC1 inhibition impairs activation of the unfolded protein response and induces cell death during ER stress in cardiomyocytes.

Christoph Hofmann, Zoe Löwenthal, Marjan Aghajani, Randal J Kaufman, Hugo A Katus, Norbert Frey, Christopher C Glembotski, Mirko Völkers, Shirin Doroudgar

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Christoph HofmannDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-3389-6582
Zoe LöwenthalDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
Marjan AghajaniDepartment of Internal Medicine and the Translational Cardiovascular Research Center, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, United States.ORCID 0000-0002-7617-271X
Randal J KaufmanDegenerative Diseases Program, Center for Genetic Disorders and Aging Research, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, United States.ORCID 0000-0003-4277-316X
Hugo A KatusDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
Norbert FreyDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.
Christopher C GlembotskiSDSU Heart Institute and Department of Biology, San Diego State University, San Diego, California, United States.
Mirko VölkersDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-2344-1856
Shirin DoroudgarDivision of Cardiology, Angiology, and Pneumology, Department of Internal Medicine III, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-8867-6010
Heidelberg University · DEUniversity of Arizona · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Baden-Württemberg Stiftung (BWS)Boehringer Ingelheim Stiftung (Boehringer Ingelheim Foundation)Deutsche Forschungsgemeinschaft (DFG)Deutsches Zentrum für Herz-Kreislaufforschung (DZHK)
6 · The paper itself

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of protein synthesis that senses and responds to a variety of stimuli to coordinate cellular metabolism with environmental conditions. To ensure that protein synthesis is inhibited during unfavorable conditions, translation is directly coupled to the sensing of cellular protein homeostasis. Thus, translation is attenuated during endoplasmic reticulum (ER) stress by direct inhibition of the mTORC1 pathway. However, residual mTORC1 activity is maintained during prolonged ER stress, which is thought to be involved in translational reprogramming and adaption to ER stress. By analyzing the dynamics of mTORC1 regulation during ER stress, we unexpectedly found that mTORC1 is transiently activated in cardiomyocytes within minutes at the onset of ER stress before being inhibited during chronic ER stress. This dynamic regulation of mTORC1 appears to be mediated, at least in part, by ATF6, as its activation was sufficient to induce the biphasic control of mTORC1. We further showed that protein synthesis remains dependent on mTORC1 throughout the ER stress response and that mTORC1 activity is essential for posttranscriptional induction of several unfolded protein response genes. Pharmacological inhibition of mTORC1 increased cell death during ER stress, indicating that the mTORC1 pathway serves adaptive functions during ER stress in cardiomyocytes potentially by controlling the expression of protective unfolded protein response genes.

Indexed as

Myocytes, CardiacSignal TransductionCell DeathEndoplasmic Reticulum StressMechanistic Target of Rapamycin Complex 1ProteinsUnfolded Protein ResponseMechanistic Target of Rapamycin Complex 1ProteinsATF6cardiomyocytescell deathER stressmTORC1

Identifiers

PMID37294892
PMCPMC10393365
OpenAlexW4379981660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.